Key Takeaways From BrightSpring Health Analyst Ratings
BrightSpring Health Analyst Ratings
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $16
BrightSpring Health Analyst Ratings
BrightSpring Health Analyst Ratings
Goldman Sachs Maintains Buy on BrightSpring Health, Lowers Price Target to $23
Deustche Upgrades BrightSpring to Buy, Cites Valuation
BrightSpring Health Analyst Ratings
Wells Fargo Initiates Brightspring Health Services at Overweight Rating With $15 Price Target
BrightSpring Health Analyst Ratings
No Data